EUVIMEDEUVIMED entdecken
Multizentrische Studie

Long-term outcomes after bioprosthetic tricuspid valve replacement: a multicenter study

Antonio Piperata iD, Jef Van den Eynde iD, Mateo Marin-Cuartas, Giacomo Bortolussi iD, Petr Fila, Tim Walter, Mehmet Cahit Sarıcaoğlu, Jan Gofus iD, Bilkhu Rajdeep, Michel Pompeu Sá, Fabrizio Rosati iD, Manuela De la Cuesta und 10 weitere

European Journal of Cardio-Thoracic Surgery · 28.03.2025 · 67 (4)

DOI: 10.1093/ejcts/ezaf107 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 24.03.2025. Verfasst von Antonio Piperata und 21 weiteren Autor:innen. Beteiligte Einrichtung: Medico-Surgical Department (Valvulopathies, Cardiac Surgery, Adult Interventional Cardiology), Hôpital Cardiologique de Haut-Lévèque, Bordeaux Univer…. Hauptthemen laut MEDLINE: Bioprosthesis, Tricuspid Valve, Heart Valve Prosthesis Implantation, Heart Valve Prosthesis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES Long-term evidence about bioprosthetic tricuspid valve replacement is scarce. This study aims to investigate the long-term clinical outcomes of patients who underwent tricuspid valve replacement with bioprostheses. METHODS This multicentre retrospective study included patients from 10 high-volume centres in 7 different countries, who underwent tricuspid valve replacement with bioprostheses. Echocardiographic and clinical data were reviewed. Long-term outcomes were investigated using Kaplan–Meier estimates, Cox regression, and competing risk analysis. RESULTS Of 675 patients, isolated tricuspid valve replacement was performed in 358 patients (53%), while 317 (47%) underwent concomitant procedures. Between these 2 groups, patients who underwent combined procedures reported a significantly higher incidence of infection, atrioventricular block, multi-organ failure, longer intensive care unit and hospital stay and higher 30-day mortality over patients who underwent isolated procedure. The overall 30-day mortality occurred in 70 patients (10.4%) [46 (14.6%) combined vs 24 (6.74%) isolated, P = 0.001]. During the follow-up, there was a continuous rate of attrition due to death, with cumulative incidences of death at 5, 10 and 15 years being 27.2%, 46.2% and 60.6%, respectively. In contrast, the risk of reintervention starts to significantly increase after 10 years of follow-up, with cumulative incidences of reintervention being 6.1%, 10.8% and 23.3%, respectively. Freedom from tricuspid valve reintervention, pacemaker implantation, tricuspid valve endocarditis and major thromboembolic events at 15 years were 56.5%, 77.3%, 84.0% and 86.4%, respectively. CONCLUSIONS Tricuspid valve replacement with bioprostheses is an effective treatment for valvular disease, despite being associated with relatively high early and long-term mortality. However, the risk of structural valve degeneration rises significantly after 10 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioprosthesisTricuspid ValveHeart Valve Prosthesis ImplantationHeart Valve ProsthesisHeart Valve DiseasesHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTreatment OutcomePostoperative ComplicationsAdultFollow-Up Studies

Stichwörter der Autor:innen

BioprosthesisTricuspid valveTricuspid valve replacementValve surgery

Autor:innen und Institutionen

  • Medico-Surgical Department (Valvulopathies, Cardiac Surgery, Adult Interventional Cardiology), Hôpital Cardiologique de Haut-Lévèque, Bordeaux University Hospital, Bordeaux, France.
  • Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
  • Department of Cardiac Surgery, Leipzig Heart Center, Leipzig, Germany.
  • Department of Cardiac Surgery, IRCCS Policlinico San Donato, Milan, Italy.
  • Centre of Cardiovascular Surgery and Transplantation, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Universitatslinikum Freiburg/Standort Bad kr Krozingen, Baden-Württemberg, Freiburg, Germany.

ORCID-Profile: Antonio Piperata, Jef Van den Eynde, Giacomo Bortolussi, Jan Gofus, Fabrizio Rosati, Julien Ternacle, Carlo de Vincentiis, Martin Czerny, Michael A Borger

Zitieren

APA

Piperata, A., Van den Eynde, J., Marin-Cuartas, M., Bortolussi, G., Fila, P., Walter, T., Sarıcaoğlu, M. C., Gofus, J., Rajdeep, B., Sá, M. P., Rosati, F., De la Cuesta, M., Gastino, E., Cuko, B., Ternacle, J., de Vincentiis, C., Czerny, M., Akar, A. R., Lucchese, G., …, & Modine, T. (2025). Long-term outcomes after bioprosthetic tricuspid valve replacement: a multicenter study. European Journal of Cardio-Thoracic Surgery, 67(4). https://doi.org/10.1093/ejcts/ezaf107

Vancouver

Piperata A, Van den Eynde J, Marin-Cuartas M, Bortolussi G, Fila P, Walter T, et al. Long-term outcomes after bioprosthetic tricuspid valve replacement: a multicenter study. European Journal of Cardio-Thoracic Surgery. 2025;67(4). doi:10.1093/ejcts/ezaf107

BibTeX
@article{Piperata2025,
  author = {Piperata, Antonio and Van den Eynde, Jef and Marin-Cuartas, Mateo and Bortolussi, Giacomo and Fila, Petr and Walter, Tim and Sarıcaoğlu, Mehmet Cahit and Gofus, Jan and Rajdeep, Bilkhu and Sá, Michel Pompeu and Rosati, Fabrizio and De la Cuesta, Manuela and Gastino, Elisa and Cuko, Besart and Ternacle, Julien and de Vincentiis, Carlo and Czerny, Martin and Akar, Ahmet Rüçhan and Lucchese, Gianluca and Ramlawi, Basel and Borger, Michael A and Modine, Thomas},
  title = {Long-term outcomes after bioprosthetic tricuspid valve replacement: a multicenter study},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  volume = {67},
  number = {4},
  doi = {10.1093/ejcts/ezaf107}
}
Kostenlos starten →